Revision history of "RESEARCH AND DEVELOPMENT OF A BIOSIMILAR DRUG BASED ON THE MONOCLONAL ANTIBODY DENOSUMAB." (Q3193262)

7 March 2024

• curprev 19:1519:15, 7 March 2024‎ DG Regio talk contribs‎ 54,037 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.7828250272425664

20 December 2023

• curprev 17:4117:41, 20 December 2023‎ DG Regio talk contribs‎ 53,749 bytes −121‎ ‎Changed an Item

12 June 2023

• curprev 14:4614:46, 12 June 2023‎ DG Regio talk contribs‎ 53,870 bytes +1,740‎ ‎Changed an Item

10 June 2023

• curprev 07:0407:04, 10 June 2023‎ Admin talk contribs‎ 52,130 bytes +437‎ BatchIngestion

18 August 2022

• curprev 08:0208:02, 18 August 2022‎ DG Regio talk contribs‎ 51,693 bytes +33,838‎ ‎Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

• curprev 16:1216:12, 16 January 2022‎ DG Regio talk contribs‎ 17,855 bytes +1,704‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

17 December 2021

• curprev 18:0118:01, 17 December 2021‎ DG Regio talk contribs‎ 16,151 bytes +1,797‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

9 December 2021

• curprev 18:2718:27, 9 December 2021‎ DG Regio talk contribs‎ 14,354 bytes +1,747‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

4 December 2021

• curprev 22:1422:14, 4 December 2021‎ DG Regio talk contribs‎ 12,607 bytes +1,765‎ ‎Changed label, description and/or aliases in fr, and other parts: Adding French translations

12 October 2021

• curprev 21:5921:59, 12 October 2021‎ DG Regio talk contribs‎ 10,842 bytes +148‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 21:5921:59, 12 October 2021‎ DG Regio talk contribs‎ 10,694 bytes +1,506‎ ‎Created claim: summary (P836): mAbxience Research, a biotechnology company belonging to the Insud pharma group (formerly CHEMO group), through the project entitled: “Research and development of a biosimilar drug based on Denosumab’s monoclonal antibody for the treatment of osteoporosis” aims to develop the first biosimilar denosumab biosimilar in Spain and Europe for the treatment of osteoporosis and bone tissue cancer that meets the requirements established by regulatory age...

11 October 2021

• curprev 15:4215:42, 11 October 2021‎ DG Regio talk contribs‎ 9,188 bytes +433‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates

10 October 2021

• curprev 11:2011:20, 10 October 2021‎ DG Regio talk contribs‎ 8,755 bytes +508‎ ‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location

8 October 2021

• curprev 15:0715:07, 8 October 2021‎ DG Regio talk contribs‎ 8,247 bytes −10‎ ‎Changed label, description and/or aliases in en
• curprev 15:0715:07, 8 October 2021‎ DG Regio talk contribs‎ 8,257 bytes +8,257‎ ‎Created a new Item